Marijuana remains probably the most highly mistreated drug in the usa. The arguments for and from the legalization of marijuana still escalate. This piece isn’t meant to set happens for any legalization debate about marijuana. Rather, I would like caution practitioners whose patients under their care test positive for marijuana. Marijuana me is still forbidden by Federal law and patients who self-medicate or abuse marijuana shouldn’t be prescribed controlled substances.
Regrettably, many physicians are frequently confronted with the dilemma of if you should prescribe controlled substances to patients who drug test positive for marijuana. Many of the the situation in claims that have modified condition laws and regulations to legalize marijuana. These alterations in condition law don’t alter the Federal guidelines that physicians are required to follow. Like a former career DEA agent, I help remind physicians that marijuana continues to be an unlawful Schedule I controlled substance without any recognized medical use within the U.S. The reality is that condition laws and regulations have Federal oversight, as mentioned within the Supremacy Clause from the Metabolic rate. “The Supremacy Clause is really a clause within Article Mire from the U.S. Metabolic rate which dictates that federal law may be the supreme law from the land. Underneath the doctrine of preemption, which is dependant on the Supremacy Clause, federal law preempts condition law, even if your laws and regulations conflict.”(1)
Whenever a physician becomes conscious that someone is applying marijuana, alternate ways of therapy ought to be implemented apart from prescribing controlled substances. Physicians also needs to do something to touch on the individual for treatment and cessation or no illegal drug abuse is revealed, including marijuana. Physicians also needs to bear in mind the marijuana created today is a lot more potent compared to past and taking advantage of high potency marijuana along with controlled substances isn’t safe for patients.
Can there be this type of factor as Food and drug administration approved medicinal marijuana? There’s two Food and drug administration approved drugs within the U.S. that contains an artificial analogue of THC (tetrahydrocannabinol), the principal chemical (cannabinoid) accountable for marijuana’s psychoactive effects. An artificial form of THC is within the Food and drug administration approved drugs Marinol (Schedule III) and Cesamet (Schedule II) that are prescribed to deal with nausea for cancer patients undergoing chemotherapy. Marinol can also be prescribed to stimulate hunger of cancer and anorexia patients (2). The Food and drug administration is presently overseeing trials being conducted on Epidiolex (3), a medication made by GW Pharmaceuticals and designed to reduce convulsive seizures in youngsters. The drug contains cannabinoids from marijuana, known as cannabidiol or CBD, which doesn’t retain the psychoactive qualities of traditional marijuana and doesn’t create a high. If the drug receives Food and drug administration approval, it might make history to be the first approved drug that contains CBD within the U.S.
Furthermore, DEA has issued a unique registration to some research laboratory in the College of Mississippi growing various strains of marijuana for numerous studies (4). These studies continues, but at this moment, ingesting or smoking botanical marijuana or even the cannabis plant is not federally approved being an recognized treatment within the U.S. Patients who smoke or consume marijuana have to be aware that they’re breaking Federal law and is prosecuted under Federal statutes. In addition, physicians ought to be testing for marijuana use and when detected, they ought to not prescribe controlled substances, no matter their diagnosis and also the patient’s signs and symptoms, according to current Federal statutes.